L
Langmu Bio operates a Quasium™ platform that produces monodisperse microspheres at kilogram scale using quasi‑equilibrium detachment technology. The company supplies precision functional microspheres for applications in drug purification, drug delivery, carbon capture, and energy storage. Its continuous manufacturing approach enables scalable production across four key industries.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Langmu Bio operates a Quasium™ platform that produces monodisperse microspheres at kilogram scale using quasi‑equilibrium detachment technology. The company supplies precision functional microspheres for applications in drug purification, drug delivery, carbon capture, and energy storage. Its continuous manufacturing approach enables scalable production across four key industries.